Two University of Chicago physician researchers contributed to the largest NIH study ever to evaluate whether lower blood pressure than previously recommended for certain patient groups reduces the risk of heart and kidney disease, stroke, and age-related memory decline.
High blood pressure is the leading cause of death and disability worldwide, according to the NIH, with more than 60 percent of those 65 and older suffering from it. The study made national headlines earlier this year when the government stopped the major portion of the trial two years early due because the results were abundantly clear: the lower, the better.
George Bakris, MD, Director of UChicago’s Comprehensive Hypertension Center helped design the Systolic Blood Intervention Trial (SPRINT). Arlene Chapman, MD, Director of the UChicago Institute for Translational Medicine’s (ITM) Clinical Resource Center (CRC), was one of the investigators at more than 100 medical centers and clinics across the country who recruited and evaluated patients for the study.
“The early discontinuation of the trial suggests that we have been undertreating hypertension for a long time,” Chapman said. Read more about their contributions to this trial on the ITM website.